Search results
Results from the WOW.Com Content Network
Menotropin (also called human menopausal gonadotropin or hMG) is a hormonally active medication for the treatment of fertility disturbances. Frequently the plural is used as the medication is a mixture of gonadotropins. Menotropins are extracted from the urine of postmenopausal women. [1]
However, for older men and postmenopausal women, this gap is much narrower as postmenopausal women are at higher risk of cardiovascular disease than premenopausal women. [ 134 ] [ 135 ] Overall, males are more likely to suffer from cancer , with much of this driven by lung cancer .
The Women's Health Initiative (WHI) is an ongoing study of over 27,000 women that began in 1991, with the most recent analyses suggesting that, when initiated within 10 years of menopause, HRT reduces all-cause mortality and risks of coronary disease, osteoporosis, and dementia; after 10 years the beneficial effects on mortality and coronary ...
A study of a population of French women from 1670 and 1789 shows that those who married at age 20–24 had 7.0 children on average and 3.7% remained childless. Women who married at age 25–29 years had a mean of 5.7 children and 5.0% remained childless. Women who married at 30–34 years had a mean of 4.0 children and 8.2% remained childless. [20]
Shepherd noted that women who take medications for weight loss during menopause should pay special attention to their diet and exercise in order to not exacerbate the loss of muscle mass and bone ...
Gender-affirming hormone therapy (GAHT), also called hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity.
[8] [9] In men, they are being investigated in the treatment of benign prostatic hyperplasia [10] and also as potential contraceptive agents. [11] GnRH antagonists could be used as puberty blockers in transgender youth and to suppress sex hormone levels in transgender adolescents and adults.
For instance, a recent Varo Bank survey found that women are significantly more likely than men to be living paycheck-to-paycheck, with 59% of female respondents saying as much compared to 41% of men.